Research on the Problems and Countermeasures of the Landing of Negotiated Drugs  

作　　者：Hu Xiaoting Chen Binbin Dong Li Sun Lihua 

机构地区：[1]School of Business Administration,Shenyang Pharmaceutical University,Shenyang 110016,China

出　　处：《Asian Journal of Social Pharmacy》2024年第3期225-231,共7页亚洲社会药学（英文）

摘　　要：Objective To provide reference for better landing of the negotiated drugs in the future.Methods Relevant data on the negotiated drugs in designated medical institutions and retail pharmacies from the website of the Medical Security Bureau was obtained,and then the allocation and problems of negotiated drugs were summarized and analyzed.Results and Conclusion The main problem for the landing of negotiated drugs is the difficulty of using them in medical institutions.First,there is a small number of designated medical institutions that can use some negotiated drugs.Second,the negotiated drugs vary greatly in the designated medical institutions.Lastly,some designated retail pharmacies do not supply the negotiated drugs.The difficulties in using the negotiated drugs can include subjective reasons and objective reasons.Retail pharmacies are not the official places where patients can use the negotiated drugs.Besides,if medical institutions do not supply and use negotiated drugs,it will pose a great risk to drug safety.Negotiated drugs should be used in designated medical institutions ultimately,which is conducive to safeguarding the rational drug use for patients.

关 键 词：negotiated drug medical institution EQUIPMENT 

分 类 号：R95[医药卫生—药学]